C4 THERAPEUTICS INC's ticker is CCCC and the CUSIP is 12529R107. A total of 1 filers reported holding C4 THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $666 | -53.1% | 357,988 | -30.7% | 0.00% | -50.0% |
| Q2 2023 | $1,421 | +38.8% | 516,898 | +58.5% | 0.00% | +100.0% |
| Q1 2023 | $1,024 | +433.3% | 326,080 | +903.3% | 0.00% | – |
| Q4 2022 | $192 | -100.0% | 32,500 | -48.2% | 0.00% | -100.0% |
| Q3 2022 | $551,000 | +533.3% | 62,800 | +446.1% | 0.00% | – |
| Q2 2022 | $87,000 | -91.4% | 11,500 | -63.3% | 0.00% | -100.0% |
| Q4 2021 | $1,008,000 | – | 31,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COMMODORE CAPITAL LP | 481,094 | $17,795,000 | 7.09% |
| Bain Capital Life Sciences Investors, LLC | 1,642,209 | $60,745,000 | 3.44% |
| Soleus Capital Management, L.P. | 464,068 | $17,166,000 | 3.09% |
| Cormorant Asset Management, LP | 2,490,065 | $92,107,000 | 2.05% |
| P.A.W. CAPITAL CORP | 50,000 | $1,850,000 | 1.63% |
| Perceptive Advisors | 3,158,566 | $116,835,000 | 1.48% |
| SPHERA FUNDS MANAGEMENT LTD. | 497,136 | $18,389,000 | 1.41% |
| Mizuho Securities Co. Ltd. | 169,392 | $6,266,000 | 1.30% |
| RTW INVESTMENTS, LP | 2,149,228 | $79,437,000 | 1.24% |
| Darwin Global Management, Ltd. | 140,034 | $5,180,000 | 1.01% |